Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Mol Sci. 2012;13(5):6352-69. doi: 10.3390/ijms13056352. Epub 2012 May 23.

Revealing the anti-tumor effect of artificial miRNA p-27-5p on human breast carcinoma cell line T-47D.

Author information

1
Department of Life Science, Institute of Molecular and Cellular Biology, National Taiwan University, Taipei 106, Taiwan; E-Mails: angus8921@gmail.com (C.-W.T.); b90206002@ntu.edu.tw (Y.-Y.C.); chung8421@yahoo.com.tw (C.-C.H.); jerris2004@gmail.com (J.-Y.C.).

Abstract

microRNAs (miRNAs) cause mRNA degradation or translation suppression of their target genes. Previous studies have found direct involvement of miRNAs in cancer initiation and progression. Artificial miRNAs, designed to target single or multiple genes of interest, provide a new therapeutic strategy for cancer. This study investigates the anti-tumor effect of a novel artificial miRNA, miR P-27-5p, on breast cancer. In this study, we reveal that miR P-27-5p downregulates the differential gene expressions associated with the protein modification process and regulation of cell cycle in T-47D cells. Introduction of this novel artificial miRNA, miR P-27-5p, into breast cell lines inhibits cell proliferation and induces the first "gap" phase (G1) cell cycle arrest in cancer cell lines but does not affect normal breast cells. We further show that miR P-27-5p targets the 3'-untranslated mRNA region (3'-UTR) of cyclin-dependent kinase 4 (CDK4) and reduces both the mRNA and protein level of CDK4, which in turn, interferes with phosphorylation of the retinoblastoma protein (RB1). Overall, our data suggest that the effects of miR p-27-5p on cell proliferation and G1 cell cycle arrest are through the downregulation of CDK4 and the suppression of RB1 phosphorylation. This study opens avenues for future therapies targeting breast cancer.

KEYWORDS:

breast cancer; cell cycle; cyclin-dependent kinase 4; exon array; miR P-27-5p; retinoblastoma protein

PMID:
22754369
PMCID:
PMC3382822
DOI:
10.3390/ijms13056352
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
    Loading ...
    Support Center